[Federal Register: September 29, 2008 (Volume 73, Number 189)]
[Notices]
[Page 56613]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr29se08-109]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances; Notice of Registration
By Notice dated June 19, 2008 and published in the Federal Register
on June 27, 2008 (73 FR 36571), Aptuit (Allendale) Inc., 75 Commerce
Drive, Allendale, New Jersey 07401, made application by renewal to the
Drug Enforcement Administration (DEA) to be registered as an importer
of Noroxymorphone (9668), a basic class of controlled substance listed
in schedule II.
The company plans to import the basic class of controlled substance
for clinical trials and research.
No comments or objections have been received. DEA has considered
the factors in 21 U.S.C. 823(a) and 952(a) and determined that the
registration of Aptuit (Allendale) Inc. to import the basic classes of
controlled substances is consistent with the public interest, and with
United States obligations under international treaties, conventions, or
protocols in effect on May 1, 1971, at this time. DEA has investigated
Aptuit (Allendale) Inc. to ensure that the company's registration is
consistent with the public interest. The investigation has included
inspection and testing of the company's physical security systems,
verification of the company's compliance with state and local laws, and
a review of the company's background and history. Therefore, pursuant
to 21 U.S.C. 952(a) and 958(a), and in accordance with 21 CFR 1301.34,
the above named company is granted registration as an importer of the
basic class of controlled substance listed.
Dated: September 22, 2008.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. E8-22882 Filed 9-26-08; 8:45 am]
BILLING CODE 4410-09-P